JP Morgan Chase
INSP icon

JP Morgan Chase’s Inspire Medical Systems INSP Stock Holding History

JP Morgan Chase’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40,000
Closed -$7.42M – 7517
2024
Q4 		$7.42M Buy
+40,000
New +$7.76M ﹤0.01% 2997
2024
Q1 		– Sell
-7,300
Closed -$1.49M – 7628
2023
Q4 		$1.49M Buy
+7,300
New +$1.18M ﹤0.01% 4062
2023
Q2 		– Sell
-6,000
Closed -$1.4M – 7114
2023
Q1 		$1.4M Buy
+6,000
New +$1.52M ﹤0.01% 3802

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase's INSP Position: Q2 2026 in Review

JP Morgan Chase reduced its Inspire Medical Systems (INSP) stake by 22% in Q2 2026, selling an estimated $551K and leaving 41,988 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #4211.

JP Morgan Chase first reported a position in INSP in Q2 2018 and has held it in 33 quarters since. The position peaked at $157M in Q3 2024. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • JP Morgan Chase held 41,988 shares of Inspire Medical Systems worth $1.94M as of Q2 2026.
  • JP Morgan Chase sold 11,627 Inspire Medical Systems shares in Q2 2026, an estimated $551K.
  • Inspire Medical Systems made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4211 holding.
  • JP Morgan Chase first reported a position in Inspire Medical Systems in Q2 2018 and has held it in 33 quarters since.
  • JP Morgan Chase's Inspire Medical Systems position peaked at $157M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.